New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Zentalis Pharmaceuticals, Inc.
ZNTL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

213M

Biotechnology

Next Earning date - 04 Nov 2024

213M

Biotechnology

Next Earning date - 04 Nov 2024

2.99USD
Shape0.05 ( 1.70%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-37%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated October 13, 2024
1W -3.86 % 1M -18.75 % 3M -24.87 % 1Y -84.07 %

Key Metrics

Shape
  • Market Cap

    212.61M


  • Shares Outstanding

    71.11M


  • Share in Float

    61.33M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    2.99


  • Average Volume

    1.77M


  • Beta

    1.701


  • Range

    2.83-19.14


  • Industry

    Biotechnology


  • Website

    https://zentalis.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.98x

P/S Ratio

0.56x

P/B Ratio

0.1

Debt/Equity

-456.2%

Net Margin

$-2.6

EPS

How ZNTL compares to sector?

P/E Ratio

Relative Strength

Shape

ZNTL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

ShapeNaN%

2025-Revenue

$3.56

Shape-187%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wedbush

upgrade

Previous: Hold

2024-08-12

Now: Neutral

UBS

downgrade

Previous: Not converted

2024-06-20

Now: Neutral

Jefferies

downgrade

Previous: Not converted

2024-06-18

Now: Hold

Morgan Stanley

downgrade

Previous: Equal-Weight

2024-06-18

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.96
vs -0.09

Q4.22

arrow
arrow

N/A

-0.92
vs -1.11

Q1.23

arrow
arrow

N/A

-1.07
vs -1.31

Q2.23

arrow
arrow

N/A

-1.85
vs -1.34

Q3.23

arrow
arrow

N/A

-0.79
vs -0.96

Q4.23

arrow
arrow

N/A

-0.83
vs -0.92

Q1.24

arrow
arrow

+113%

0.14
vs -1.07

Q2.24

arrow
arrow

N/A

-1.24
vs -1.85

Q3.24

arrow
arrow

N/A

-0.91
vs -0.79

Q4.24

arrow
arrow

N/A

-0.97
vs -0.83

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.1M  vs NA

Q1.24

arrow
arrow

NA

40.6M  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.13

Q4.22

arrow
arrow

-11%

-0.11
vs -0.12

Q1.23

arrow
arrow

-16%

-0.16
vs -0.11

Q2.23

arrow
arrow

-22%

-0.22
vs -0.16

Q3.23

arrow
arrow

-12%

-0.12
vs -0.22

Q4.23

arrow
arrow

-14%

-0.14
vs -0.12

Q1.24

arrow
arrow

+2%

0.02
vs -0.14

Q2.24

arrow
arrow

-23%

-0.23
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

120

120
vs 118

2%

Q4.22

arrow
arrow

107

107
vs 120

-11%

Q1.23

arrow
arrow

110

110
vs 107

3%

Q2.23

arrow
arrow

136

136
vs 110

24%

Q3.23

arrow
arrow

140

140
vs 136

3%

Q4.23

arrow
arrow

123

123
vs 140

-12%

Q1.24

arrow
arrow

141

141
vs 123

15%

Q2.24

arrow
arrow

144

144
vs 141

2%

Earnings Growth

Latest News